新股孖展统计 | 9月12日

Core Viewpoint - Jinfang Pharmaceutical-B (02595) is currently in the process of an IPO, with significant oversubscription indicating strong investor interest [1] Group 1: IPO Details - As of September 12, a total of HKD 379.8185 billion has been lent by brokers including Futu, Huatai, and others for Jinfang Pharmaceutical-B's IPO, resulting in an oversubscription of over 239 times [1][2] - The total amount raised from the IPO is HKD 1.58 billion [2] Group 2: Broker Contributions - Futu contributed HKD 187.90 billion, while Huatai contributed HKD 65.00 billion [2] - Other brokers such as Ruch, Xincheng, and Yaocai also participated, with smaller contributions totaling HKD 79.4789 billion [2]